Palo Alto Investors LP Long-Term Concentrated

Location: Palo Alto, CA

CIK: 0001306923 · Show all filings

Period: Q4 2017 (← Previous) (Next →)

Filing Date: Feb 14, 2018

Total Value: $2.322B (100.0% shares, 0.0% debt)

Holdings (37)

— ABIOMED INC 12.8%
Value $297M Shares 1,585,413 Share Price $187.41 Est. Cost/Share $32.04 Unrealized @ Report Date —
UTHR UNITED THERAPEUTICS CORP DEL 10.2%
Value $238M Shares 1,606,250 Share Price $147.95 * Est. Cost/Share $88.34 Unrealized @ Report Date +43.9%
— CLOVIS ONCOLOGY INC 10.0%
Value $231M Shares 3,402,781 Share Price $68.00 Est. Cost/Share $54.40 Unrealized @ Report Date —
BMRN BIOMARIN PHARMACEUTICAL INC 9.6%
Value $223M Shares 2,497,806 Share Price $89.17 * Est. Cost/Share $79.67 Unrealized @ Report Date +9.1%
INSM INSMED INC 8.6%
Value $200M Shares 6,404,586 Share Price $31.18 * Est. Cost/Share $15.54 Unrealized @ Report Date +90.1%
— ALEXION PHARMACEUTICALS INC 5.8%
Value $134M Shares 1,117,642 Share Price $119.59 Est. Cost/Share $121.07 Unrealized @ Report Date —
— SAGE THERAPEUTICS INC 5.8%
Value $134M Shares 810,806 Share Price $164.71 Est. Cost/Share $46.14 Unrealized @ Report Date —
FOLD AMICUS THERAPEUTICS INC 3.7%
Value $86.43M Shares 6,006,022 Share Price $14.39 * Est. Cost/Share $6.23 Unrealized @ Report Date +120.4%
— EPIZYME INC 3.7%
Value $86.1M Shares 6,860,843 Share Price $12.55 Est. Cost/Share $15.12 Unrealized @ Report Date —
— IMMUNOMEDICS INC 3.3%
Value $77.15M Shares 4,774,261 Share Price $16.16 Est. Cost/Share $11.54 Unrealized @ Report Date —
VNDA VANDA PHARMACEUTICALS INC 2.7%
Value $63.17M Shares 4,155,670 Share Price $15.20 * Est. Cost/Share $8.70 Unrealized @ Report Date +70.5%
— WRIGHT MED GROUP N V 2.6%
Value $60.75M Shares 2,736,293 Share Price $22.20 Est. Cost/Share $23.42 Unrealized @ Report Date —
STAA STAAR SURGICAL CO 2.3%
Value $54.2M Shares 3,496,752 Share Price $15.50 * Est. Cost/Share $8.00 Unrealized @ Report Date +85.7%
ACAD ACADIA PHARMACEUTICALS INC 2.1%
Value $49.41M Shares 1,641,030 Share Price $30.11 * Est. Cost/Share $29.82 Unrealized @ Report Date +7.2%
ALGN ALIGN TECHNOLOGY INC 2.0%
Value $47.22M Shares 212,507 Share Price $222.19 * Est. Cost/Share $94.04 Unrealized @ Report Date +141.5%
— AMAG PHARMACEUTICALS INC 2.0%
Value $46.28M Shares 3,493,220 Share Price $13.25 Est. Cost/Share $29.37 Unrealized @ Report Date —
— AIMMUNE THERAPEUTICS INC 1.9%
Value $43.36M Shares 1,146,419 Share Price $37.82 Est. Cost/Share $22.25 Unrealized @ Report Date —
PRTA PROTHENA CORP PLC 1.8%
Value $41.08M Shares 1,095,655 Share Price $37.49 * Est. Cost/Share $32.98 Unrealized @ Report Date +54.4%
— KARYOPHARM THERAPEUTICS INC 1.5%
Value $34.03M Shares 3,544,439 Share Price $9.60 Est. Cost/Share $19.57 Unrealized @ Report Date —
— CELGENE CORP 1.4%
Value $32.14M Shares 307,940 Share Price $104.36 Est. Cost/Share $97.79 Unrealized @ Report Date —
— MOMENTA PHARMACEUTICALS INC 1.1%
Value $25.41M Shares 1,821,576 Share Price $13.95 Est. Cost/Share $14.12 Unrealized @ Report Date —
— ALDER BIOPHARMACEUTICALS INC 0.9%
Value $21.07M Shares 1,840,246 Share Price $11.45 Est. Cost/Share $11.48 Unrealized @ Report Date —
— SHIRE PLC 0.9%
Value $21.07M Shares 135,800 Share Price $155.12 Est. Cost/Share $216.61 Unrealized @ Report Date —
EXAS EXACT SCIENCES CORP 0.7%
Value $16.33M Shares 310,876 Share Price $52.54 Est. Cost/Share $13.61 Unrealized @ Report Date +292.2%
— RIGEL PHARMACEUTICALS INC 0.7%
Value $15.27M Shares 3,935,584 Share Price $3.88 Est. Cost/Share $3.40 Unrealized @ Report Date —
— BIOVERATIV INC 0.6%
Value $14.26M Shares 264,400 Share Price $53.92 Est. Cost/Share $56.44 Unrealized @ Report Date —
GILD GILEAD SCIENCES INC 0.5%
Value $12.6M Shares 175,900 Share Price $71.64 * Est. Cost/Share $62.02 Unrealized @ Report Date -9.9%
— DICERNA PHARMACEUTICALS INC 0.2%
Value $4.523M Shares 500,913 Share Price $9.03 Est. Cost/Share $5.39 Unrealized @ Report Date —
— SUNESIS PHARMACEUTICALS INC 0.2%
Value $4.29M Shares 1,162,473 Share Price $3.69 Est. Cost/Share $4.37 Unrealized @ Report Date —
— ALIMERA SCIENCES INC 0.2%
Value $4.008M Shares 3,013,793 Share Price $1.33 Est. Cost/Share $4.88 Unrealized @ Report Date —
— IDERA PHARMACEUTICALS INC 0.1%
Value $1.301M Shares 616,355 Share Price $2.11 Est. Cost/Share $3.70 Unrealized @ Report Date —
— ZOGENIX INC 0.1%
Value $1.181M Shares 29,500 Share Price $40.03 Est. Cost/Share $13.36 Unrealized @ Report Date —
CYTK CYTOKINETICS INC 0.0%
Value $1.008M Shares 123,686 Share Price $8.15 * Est. Cost/Share $6.71 Unrealized @ Report Date +69.1%
— MELINTA THERAPEUTICS INC 0.0%
Value $801K Shares 50,689 Share Price $15.80 Est. Cost/Share $15.80 Unrealized @ Report Date —
— HISTOGENICS CORP 0.0%
Value $621K Shares 302,922 Share Price $2.05 Est. Cost/Share $11.00 Unrealized @ Report Date —
— SOPHIRIS BIO INC 0.0%
Value $561K Shares 247,000 Share Price $2.27 Est. Cost/Share $2.60 Unrealized @ Report Date —
— TREVENA INC 0.0%
Value $546K Shares 341,300 Share Price $1.60 Est. Cost/Share $2.30 Unrealized @ Report Date —